1. Home
  2. CASI vs JRSH Comparison

CASI vs JRSH Comparison

Compare CASI & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • JRSH
  • Stock Information
  • Founded
  • CASI 1991
  • JRSH 2016
  • Country
  • CASI China
  • JRSH United States
  • Employees
  • CASI N/A
  • JRSH N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • JRSH Apparel
  • Sector
  • CASI Health Care
  • JRSH Consumer Discretionary
  • Exchange
  • CASI Nasdaq
  • JRSH Nasdaq
  • Market Cap
  • CASI 35.8M
  • JRSH 41.7M
  • IPO Year
  • CASI 1996
  • JRSH 2018
  • Fundamental
  • Price
  • CASI $2.28
  • JRSH $3.47
  • Analyst Decision
  • CASI Strong Buy
  • JRSH Strong Buy
  • Analyst Count
  • CASI 1
  • JRSH 1
  • Target Price
  • CASI $4.00
  • JRSH $4.00
  • AVG Volume (30 Days)
  • CASI 384.8K
  • JRSH 28.4K
  • Earning Date
  • CASI 11-13-2025
  • JRSH 11-11-2025
  • Dividend Yield
  • CASI N/A
  • JRSH 5.76%
  • EPS Growth
  • CASI N/A
  • JRSH N/A
  • EPS
  • CASI N/A
  • JRSH 0.07
  • Revenue
  • CASI $31,564,000.00
  • JRSH $144,505,598.00
  • Revenue This Year
  • CASI N/A
  • JRSH $7.62
  • Revenue Next Year
  • CASI N/A
  • JRSH $8.35
  • P/E Ratio
  • CASI N/A
  • JRSH $52.89
  • Revenue Growth
  • CASI 36.64
  • JRSH 17.11
  • 52 Week Low
  • CASI $1.09
  • JRSH $2.81
  • 52 Week High
  • CASI $7.55
  • JRSH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • CASI 55.66
  • JRSH 62.29
  • Support Level
  • CASI $2.18
  • JRSH $3.42
  • Resistance Level
  • CASI $2.49
  • JRSH $3.50
  • Average True Range (ATR)
  • CASI 0.19
  • JRSH 0.08
  • MACD
  • CASI -0.03
  • JRSH 0.01
  • Stochastic Oscillator
  • CASI 33.33
  • JRSH 85.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: